View in EDS

Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism.

Saved in:
Bibliographic Details
Title: Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism.
Authors: He Q; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Tao F; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Wen X; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Zhu L; Department of Traditional Chinese Medicine Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China., Ye X; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China. YeXuxing6857@163.com.
Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2026 Jul 14; Vol. 43 (4). Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7276
DOI:10.1007/s10585-026-10418-w